Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

6.670 -0.400 (-5.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
61 62 Next >
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
 Gainers 
Via Benzinga
Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak
In the U.S., Novavax is going after the 10% of unvaccinated adults. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022
Upgrades 
Via Benzinga
Europe Approves Novavax's COVID-19 Vaccine Booster For Adults
Via Benzinga
What Is Going on With Accenture (ACN) Stock Today?
Accenture (ACN) stock is on the move Thursday after releasing a positive earnings report and announcing a new acquisition. 
Via InvestorPlace
Novavax Price Target Cut By Around 80%, Plus This Analyst Predicts $129 For NIKE
Morgan Stanley cut the price target for NIKE, Inc. (NYSE: NKE) from $149 to $129. NIKE shares fell 0.6% to $99.20 on Thursday. 
Via Benzinga
Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement
Spero Therapeutics (SPRO) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (GSK). 
Via InvestorPlace
Why Is Novavax (NVAX) Stock Falling Today?
Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again. 
Via InvestorPlace
Why Novavax Stock Is Trading Lower Today
Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following bearish analyst coverage from JPMorgan.  
Via Benzinga
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem... 
Via Benzinga
US Stock Futures Rise Following Wednesday's Plunge
Pre-open movers 
Via Benzinga
Novavax Remains a Risk-On Stock in a Risk-Off Market
NVAX is a risk-on stock at a time investors are turning to risk-off assets. This article looks to see if Novavax still presents an opportunity for investors 
Via MarketBeat
Topics Earnings
Exposures Financial
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022. 
Via Talk Markets
Nikola, Super Micro Computer And Other Big Losers From Monday
U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
Vaccine stocks are taking it on the chin following President Joe Biden's comments that the "pandemic is over." What now? 
Via InvestorPlace
Why BioNTech, Moderna And Novavax Shares Are Diving
BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 297 companies achieved new lows for the year. 
Via Benzinga
What Is Going on With Vaxart (VXRT) Stock Today?
Vaxart released encouraging results for its oral Covid-19 vaccine, though sentiment for VXRT stock presently remains mixed. 
Via InvestorPlace
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
Health Canada has approved Moderna Inc's (NASDAQ: 
Via Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
Wall Street Journal 
Via Benzinga
HP, Ambarella, Bed Bath & Beyond And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping around 280 points on Wednesday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Why Is Novavax (NVAX) Stock Down Today?
Pfizer and Moderna received FDA approval for their omicron-specific booster. NVAX stock is hitting new 52-week lows in response. 
Via InvestorPlace
Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use... 
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.